Shareholders' Equity (Tables)

3 Months Ended

Mar. 31, 2025

Stockholders' Equity Note [Abstract]

Schedule of the impact of stock-based compensation expense

The Company recorded stock-based compensation expense as follows in the unaudited condensed consolidated statements of operations and comprehensive income (in millions):

	Three Months Ended March 31,
	2025		2024
Stock options	$	0.5	$	0.4
Restricted stock units		4.7		4.2
Employee Stock Purchase Plan		0.4		0.2
Total stock-based compensation expense	$	5.6	$	4.8

	Three Months Ended March 31,
	2025		2024
Cost of product revenue	$	0.5	$	0.4
Selling, general and administrative		4.4		3.9
Research and development		0.7		0.5
Total stock-based compensation expense	$	5.6	$	4.8